Johnson & Johnson
Court orders J&J to pay record $4.69 bn in Baby Powder case
14 Jul 2018
A jury in the US on Thursday ordered Johnson & Johnson (J&J) to pay a record $4.69 billion to 22 women who alleged that the company’s talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer
Johnson & Johnson ordered to pay record $417 mn in talcum powder case
22 Aug 2017
Echeverria who filed the law suit alleged that Johnson & Johnson failed to adequately warn consumers even as it was fully aware of the talcum powder’s potential cancer risks
J&J, Novartis, Takeda, keen on buying controlling stake in Brazilian drug maker Hypermarcas
26 Apr 2017
Johnson & Johnson succeeds in $30-bn tender offer for Actelion
31 Mar 2017
J&J had clinched the deal in December after raising its offer to $280 per share or $30 billion in cash, which included spinning off Actelion's research and development pipeline
